Ibuprofen Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Ibuprofen Price Trend, Index and Forecast
Track the latest insights on ibuprofen price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Ibuprofen Prices Outlook Q3 2025
- USA: USD 10,827/MT
- China: USD 12,365/MT
- Germany: USD 10,670/MT
- France: USD 11,976/MT
- Indonesia: USD 11,250/MT
Ibuprofen Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the ibuprofen prices in the USA reached 10,827 USD/MT in September. Prices eased as downstream pharmaceutical converters moderated intake due to steady consumption patterns across analgesic demand. Manufacturers operated with predictable scheduling, and distributors maintained streamlined inventory management. These operating conditions encouraged formulators to procure conservatively in alignment with routine production cycles.
During the third quarter of 2025, the ibuprofen prices in China reached 12,365 USD/MT in September. The downward movement was driven by improved upstream availability as API producers optimized synthesis efficiency across several facilities. Pharmaceutical buyers adjusted procurement timing to reflect stable retail demand from over-the-counter segments. With logistics networks functioning reliably, manufacturers coordinated deliveries to maintain efficient operating continuity.
During the third quarter of 2025, the ibuprofen prices in Germany reached 10,670 USD/MT in September. Prices softened as formulators relied on existing inventories while planning replenishment based on regulated release schedules. API production sites maintained controlled operating rates, and import flows arrived consistently through established European corridors. These developments supported a measured procurement environment for local drug manufacturers.
During the third quarter of 2025, the ibuprofen prices in France reached 11,976 USD/MT in September. The downward trend reflected cautious sourcing from domestic pharmaceutical groups who kept intake aligned with stable analgesic product demand. Cross-border shipments moved predictably through regional hubs, enabling importers to manage stock with limited fluctuation. Formulation plants scheduled API usage to match ongoing production activity.
During the third quarter of 2025, the ibuprofen prices in Indonesia reached 11,250 USD/MT in September. Prices declined as domestic manufacturers synchronized procurement with moderate output levels in consumer healthcare formulations. Import-oriented buyers coordinated shipments to avoid overstocking amid steady demand. Transport corridors across major port regions operated normally, supporting consistent distribution to downstream processors.
Ibuprofen Prices Outlook Q2 2025
- USA: USD 10,992/MT
- China: USD 12,534/MT
- Germany: USD 10,790/MT
- France: USD 12,158/MT
- Indonesia: USD 11,422/MT
During the second quarter of 2025, the ibuprofen prices in the USA reached 10,992 USD/MT in June. In the USA, ibuprofen prices in Q2 2025 were impacted by supply chain constraints related to the sourcing of key active pharmaceutical ingredients from overseas suppliers. Regulatory compliance costs and batch testing requirements contributed to production expenses. Demand fluctuations in the over-the-counter pharmaceutical sector, coupled with freight and warehousing cost variations, also influenced overall pricing dynamics during the quarter.
During the second quarter of 2025, ibuprofen prices in China reached 12,534 USD/MT in June. In China, ibuprofen pricing was influenced by raw material cost volatility, particularly for isobutylbenzene and acetic acid derivatives. Plant operating rates fluctuated due to environmental audits and emissions control policies. Export volumes to key global markets affected domestic supply balances. Additionally, energy prices and workforce availability across pharmaceutical manufacturing hubs played a role in shaping cost structures and price outcomes.
During the second quarter of 2025, the ibuprofen prices in Germany reached 10,790 USD/MT in June. In Germany, ibuprofen prices were affected by pharmaceutical manufacturing activity, which was influenced by environmental regulations and energy price trends. Import costs for intermediates and feedstocks contributed to shifts in production economics. Demand from both domestic healthcare providers and private-label pharmaceutical companies remained steady. Packaging material costs and distribution inefficiencies also played a part in determining final product pricing.
During the second quarter of 2025, the ibuprofen prices in France reached 12,158 USD/MT in June. In France, ibuprofen pricing was impacted by demand from the healthcare and consumer wellness sectors, alongside changes in the cost of pharmaceutical excipients and packaging components. Domestic production levels were shaped by labor availability and regulatory oversight. Import dependency for active ingredients influenced pricing sensitivity to currency movements and freight rate changes. Seasonal demand variations further affected inventory management and supply consistency.
During the second quarter of 2025, the ibuprofen prices in Indonesia reached 11,422 USD/MT in June. In Indonesia, ibuprofen prices in Q2 2025 were influenced by import reliance on raw materials and active pharmaceutical ingredients from India and China. Currency fluctuations against the US dollar affected landed costs. Demand from hospitals, pharmacies, and government procurement channels contributed to consumption levels. Logistics and port clearance delays, combined with domestic formulation capacity limitations, further shaped the pricing environment.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the ibuprofen prices.
Europe Ibuprofen Price Trend
Q3 2025:
As per the ibuprofen price index, Europe experienced a downward movement in line with softer conditions across major consuming markets. Pharmaceutical manufacturers concentrated on balancing API intake with stable analgesic demand, refining batch scheduling to optimize release cycles. Several production facilities aligned throughput with regulatory timing requirements, shaping how formulation inventories were rotated across internal networks. Inland multimodal transport faced periodic scheduling variability, prompting organizations to strengthen internal coordination for inbound materials. These patterns influenced how production sites structured workflow planning across the region.
Q2 2025:
European ibuprofen prices in Q2 2025 were influenced by energy-intensive manufacturing costs, particularly due to electricity and gas price volatility. Regulatory compliance costs, especially related to emissions and pharmaceutical safety standards, impacted operating margins. Import dependency for key intermediates from Asia introduced price sensitivity to currency movements and freight fluctuations. Demand from the healthcare and private-label pharmaceutical sectors remained steady, shaping procurement strategies and inventory levels.
This analysis can be extended to include detailed ibuprofen price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Ibuprofen Price Trend
Q3 2025:
As per the ibuprofen price index, North America saw a downward trend driven by moderated purchasing from major generic producers. Formulators aligned procurement with consistent demand for pain-relief products, maintaining operating discipline across manufacturing hubs. Regional warehousing hubs managed predictable inbound flows, and trucking routes experienced routine seasonal congestion patterns. These logistical and operational elements informed how manufacturers arranged production cycles across key pharmaceutical corridors.
Q2 2025:
In North America, ibuprofen pricing was impacted by shifts in demand from the over-the-counter and institutional healthcare sectors. Supply chain disruptions for active pharmaceutical ingredients sourced from overseas affected production schedules. Regulatory inspection cycles and quality control requirements contributed to manufacturing costs. Additionally, distribution expenses, including warehousing and trucking rates, played a role in shaping the overall price structure during the quarter.
Specific ibuprofen historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Ibuprofen Price Trend
Q3 2025:
As per ibuprofen price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the ibuprofen pricing trends and ibuprofen price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on ibuprofen prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Ibuprofen Price Trend
Q3 2025:
Asia Pacific registered a downward movement supported by lower pricing across principal producing and consuming territories. Manufacturing centers in key economies moderated API usage while maintaining active analgesic formulation. Ocean freight routes exhibited shifts in turnaround timing, guiding import-dependent buyers to refine shipment intervals. These dynamics affected how downstream processors balanced inventory with ongoing production commitments.
Q2 2025:
In the Asia Pacific region, ibuprofen prices were shaped by fluctuations in raw material availability, particularly for isobutylbenzene and acetic acid derivatives. Plant operations in major producing countries were affected by environmental compliance checks and labor-related constraints. Export demand from Western markets influenced regional supply allocation. Currency volatility and intra-regional trade logistics further contributed to cost variability across the pharmaceutical manufacturing hubs.
This ibuprofen price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Ibuprofen Price Trend
Q3 2025:
Latin America's ibuprofen market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in ibuprofen prices.
Q2 2025:
Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting Latin America’s ability to meet international demand consistently. Moreover, the ibuprofen price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing ibuprofen pricing trends in this region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Ibuprofen Pricing Report, Market Analysis, and News
IMARC's latest publication, “Ibuprofen Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the ibuprofen market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of ibuprofen at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed ibuprofen prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ibuprofen pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Ibuprofen Industry Analysis
The global ibuprofen industry size reached USD 97.88 Million in 2025. By 2034, IMARC Group expects the market to reach USD 121.06 Million, at a projected CAGR of 2.39% during 2026-2034. Growth is supported by rising consumption of non-steroidal anti-inflammatory medications, expanding over-the-counter demand, and broader manufacturing capabilities across key pharmaceutical markets.
Latest developments in the ibuprofen industry:
- October 2025: Cumberland Pharmaceuticals Inc. announced regulatory approval in Mexico for its injectable formulation of ibuprofen, intended to manage pain and fever, especially in medical settings. The company will collaborate with PiSA Farmaceutica to deploy the product via 800 mg vials, offering a non-opioid alternative for acute post-operative care.
- January 2025: GC Green Cross launched its new product “Teksan RAY,” a 30-capsule soft-gel anti-inflammatory and pain-relief medicine in South Korea that contains ibuprofen. The company emphasised the product’s efficacy across menstrual, muscular and general pain, and highlighted its ease of use as a soft-gel capsule alternative.
Product Description
Ibuprofen (C13H18O2), also known as Motrin, refers to a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid. It also functions as a radical scavenger, geroprotector, cyclooxygenase 2 inhibitor, and non-narcotic analgesic. Colorless and crystalline, ibuprofen dissolves well in water, alcohol, and other organic solvents. Its melting point is 75-77.5 ºC, its boiling point is 157ºC, and its molecular weight is 206.28 g/mol.
Isobutylbenzene and acetic anhydride are raw materials used in the synthesis of ibuprofen. These raw materials go through the Friedel-Crafts acylation, carbonyl reduction, chloride substitution, and Grignard reaction processes. It is used to control and treat osteoarthritis, rheumatoid disorders, inflammatory diseases, mild pain, dysmenorrhea, fever, headache, tooth pain, cramping during menstruation, muscle pains, and colds. Ibuprofen is a reasonably priced, very effective medication that helps patients live better, heal more quickly, regulate body temperature, and lessen discomfort.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Ibuprofen |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Ibuprofen Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of ibuprofen pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting ibuprofen price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ibuprofen price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.